← Moderna, Inc.

Moderna, Inc.

MRNA FCF Margin

Free cash flow as a percentage of revenue, showing how much of each sales dollar becomes cash.

Latest FCF Margin: -388.3% (2026Q2); +261.0 pp YoY.

Across the 14 quarters from 2023Q1 to 2026Q2, FCF Margin ranged from -1068.5% in 2025Q1 to 131.4% in 2025Q4.

Revenue EPS Free Cash Flow Gross Margin FCF Margin Cumulative FCF Rule of 40
MRNA FCF Margin

Latest: -388.3% (2026Q2)

Healthcare Comparison

1 / 3

Other MRNA Charts

More quarter-by-quarter fundamentals for Moderna, Inc.

1 / 6